CMS announces Coverage Decision Memorandum for Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (CAG-00065R)

Triad is pleased to announce that the Centers for Medicaid and Medicaid Services (CMS) has released a final decision memo for F-18 Sodium Fluoride ( NaF) to identify bone metastasis of cancer. CMS will cover F-18 NaF PET Bone Imaging through Coverage with Evidence Development. The memo can be found using the following link:

http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?from2=viewdecisionmemo.asp&id=233&